Rabin Medical Center; Oncology Dept
About Rabin Medical Center; Oncology Dept
Rabin Medical Center is a major hospital and medical center located in Petah Tikva, Israel. It is owned and operated by Clalit Health Services, Israel's largest health maintenance organization. In January 1996, Beilinson Hospital and Hasharon Hospital were merged and renamed Rabin Medical Center.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Rabin Medical Center
6
Alpha Tau Medical LTD.
2
Incyte Corporation
1
Kalytera Therapeutics Israel, Ltd.
1
Puma Biotechnology, Inc.
1
moshe yeshurun
1
Clinical Trials at Rabin Medical Center; Oncology Dept
During the past decade, Rabin Medical Center; Oncology Dept conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on
average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
2007-06-01
2014-06-01
Completed
252
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients
2011-01-01
2013-04-01
Terminated
120
Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies
2011-08-01
2015-04-01
Unknown status
10
Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation
2012-09-01
Unknown status
30
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation
2012-07-01
Unknown status
40
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Rabin Medical Center; Oncology Dept" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Rabin Medical Center" with 6 trials
sponsored, "Alpha Tau Medical LTD." with 2 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Kalytera Therapeutics Israel, Ltd."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
Clinical Trials Conditions at Rabin Medical Center; Oncology Dept
According to Clinical.Site data, the most researched conditions in "Rabin Medical Center; Oncology Dept" are
"Graft Versus Host Disease" (2 trials), "Acute-graft-versus-host Disease" (1 trials), "Bone Marrow Failure Syndrome" (1 trials), "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Rabin Medical Center; Oncology Dept" in a lesser frequency.
Clinical Trials Intervention Types at Rabin Medical Center; Oncology Dept
Most popular intervention types in "Rabin Medical Center; Oncology Dept" are "Drug" (18 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Cannabidiol" (2 trials), "Docetaxel" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Rabin Medical Center; Oncology Dept
The vast majority of trials in "Rabin Medical Center; Oncology Dept" are
20 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Rabin Medical Center; Oncology Dept
Currently, there are NaN active trials in "Rabin Medical Center; Oncology Dept".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Rabin Medical Center; Oncology Dept,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Rabin Medical Center; Oncology Dept, 3 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".